Virtual event by B-CORE program, McLean (Mass.) Hospital to discuss COVID-19’s impact on substance use misuse and treatment
The Brigham Comprehensive Opioid Response and Education program and McLean Hospital of Belmont, Mass., on Sept. 21 at 12 p.m. ET will host a town hall virtual event, during which experts and those with experience with substance misuse and treatment will discuss COVID-19’s impact on these experiences, as well as solutions. Register here. For more information and resources from the AHA, including a recent People Matter, Words Matter poster for download, visit AHA’s website.
Related News Articles
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
The Substance Abuse and Mental Health Services Administration Jan. 7 announced it will award $1 million grants to 14 states and Washington, D.C., to take part…
Headline
The Centers for Medicare & Medicaid Services today announced Michigan, New York, Oklahoma and South Carolina state Medicaid agencies were selected to…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
The AHA Oct. 24 announced it has been awarded a nearly $1.5 million grant from the Centers for Disease Control and Prevention as part of its National…